1. Home
  2. CPHI vs LICN Comparison

CPHI vs LICN Comparison

Compare CPHI & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • LICN
  • Stock Information
  • Founded
  • CPHI N/A
  • LICN 2004
  • Country
  • CPHI China
  • LICN China
  • Employees
  • CPHI N/A
  • LICN N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • CPHI Health Care
  • LICN
  • Exchange
  • CPHI Nasdaq
  • LICN Nasdaq
  • Market Cap
  • CPHI 4.7M
  • LICN 3.8M
  • IPO Year
  • CPHI N/A
  • LICN 2023
  • Fundamental
  • Price
  • CPHI $1.78
  • LICN $3.85
  • Analyst Decision
  • CPHI
  • LICN
  • Analyst Count
  • CPHI 0
  • LICN 0
  • Target Price
  • CPHI N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • CPHI 14.2K
  • LICN 20.1K
  • Earning Date
  • CPHI 11-12-2025
  • LICN 01-01-0001
  • Dividend Yield
  • CPHI N/A
  • LICN N/A
  • EPS Growth
  • CPHI N/A
  • LICN N/A
  • EPS
  • CPHI N/A
  • LICN N/A
  • Revenue
  • CPHI $4,396,201.00
  • LICN $37,641,000.00
  • Revenue This Year
  • CPHI N/A
  • LICN N/A
  • Revenue Next Year
  • CPHI N/A
  • LICN N/A
  • P/E Ratio
  • CPHI N/A
  • LICN N/A
  • Revenue Growth
  • CPHI N/A
  • LICN N/A
  • 52 Week Low
  • CPHI $1.20
  • LICN $2.60
  • 52 Week High
  • CPHI $3.35
  • LICN $462.00
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 46.82
  • LICN 35.90
  • Support Level
  • CPHI $1.64
  • LICN $3.75
  • Resistance Level
  • CPHI $1.93
  • LICN $4.09
  • Average True Range (ATR)
  • CPHI 0.08
  • LICN 0.28
  • MACD
  • CPHI -0.03
  • LICN -0.07
  • Stochastic Oscillator
  • CPHI 38.89
  • LICN 23.08

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: